Abstract
The discovery of a pathological stage C after radical prostatectomy with a curative aim for a clinically localized cancer of the prostate raises the question of a possible adjuvant therapy. The indications and modalities of such a therapy still remain controversial. Our review sums up our knowledge and uncertainties on this point.
MeSH terms
-
Adenocarcinoma / immunology
-
Adenocarcinoma / pathology
-
Adenocarcinoma / radiotherapy*
-
Adenocarcinoma / surgery
-
Adult
-
Antigens, Neoplasm / immunology
-
Combined Modality Therapy
-
Humans
-
Lymph Node Excision
-
Male
-
Neoplasm Recurrence, Local
-
Prostatectomy
-
Prostatic Neoplasms / immunology
-
Prostatic Neoplasms / pathology
-
Prostatic Neoplasms / radiotherapy*
-
Prostatic Neoplasms / surgery